SCHEMBL5565090

SCHEMBL5565090

Cc1cc2c(s1)SN(C)C(=O)C2

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.31
GFER P55789 1/20 0.30
HSD17B10 Q99714 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30
TRIM24 O15164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3924964 0.66
SCHEMBL5570362 0.63 GAA (0.35)
SCHEMBL5565920 0.62 MEN1 (0.39) ALDH1A1TSHRTRIM24
SCHEMBL19122298 0.58
SCHEMBL13183593 0.58 PNMT (0.48) ALDH1A1TSHR
SCHEMBL1823806 0.58 NOS3 (0.39) ALDH1A1
SCHEMBL27398206 0.57 BRD4 (0.43) BRD4GFERALDH1A1TSHR
SCHEMBL8306539 0.57 MEN1 (0.37) HSD17B10ALDH1A1TSHRTRIM24
SCHEMBL10608736 0.57 GSK3A (0.33) BRD4
SCHEMBL13827392 0.56 PNMT (0.47) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1750719-A2 TREATMENT OF DISEASES ASSOCIATED WITH ALTERED LEVEL OF AMYLOID BETA PEPTIDES Boehringer Ingelheim International GmbH (DE) 2007-02-14 EP disclosed
WO-2005110422-A2 TREATMENT OF DISEASES ASSOCIATED WITH ALTERED LEVEL OF AMYLOID BETA PEPTIDES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-24 WO disclosed